FY16 estimates cut to reflect guidance, but the recent price fall means there is almost no value attributed to the growth opportunities available, which could transform the group’s prospects. 136p target price, based on CY17 RoE/PBV valuation.
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
FY16 estimates cut to reflect guidance, but the recent price fall means there is almost no value attributed to the growth opportunities available, which could transform the group’s prospects. 136p target price, based on CY17 RoE/PBV valuation.
